Tag Archives: kindness

Go the Extra Mile – Karine Duquesne

SpreadLove In Organizations
SpreadLove In Organizations
Go the Extra Mile - Karine Duquesne
/

In this conversation, Karine Duquesne, general manager of LEO Pharma France, shared insights into her approach to leadership. She emphasized the importance of authenticity, vulnerability, and kindness in leadership. She also discussed the challenges and opportunities presented by hybrid work arrangements and highlighted the significance of belonging and purpose in the workplace. Karine’s focus on innovation in healthcare was driven by a desire to offer hope and treatments that can make a difference in patients’ lives. Overall, her leadership philosophy centers on being true to oneself and creating a supportive and challenging environment for personal and professional growth.

“Be yourself to be at your best“

MEET OUR GUEST Karine Duquesne Vice President, and General Manager at LEO Pharma.

Karine Duquesne is Vice-President, and General Manager of LEO Pharma France. Karine previously held the position of General Manager at Actelion Pharmaceuticals France, and Johnson & Johnson’s rare disease subsidiary prior to its merger with Janssen in 2020.

She holds a Doctor of Pharmacy degree and has more than twenty years of experience in the pharmaceutical industry within various positions, from Medical Affairs to Head of Marketing and Sales.

Karine is French and has enriched her career with international experiences in the USA within Janssen’s Global and Strategic teams in Immunology and Neuroscience.

Karine is passionate about people development, innovation, diversity and inclusion.

Transcripts

EPISODE TRANSCRIPT: Karine Duquesne

Naji Gehchan: Hello, leaders of the world. Welcome to “Spread Love in Organizations”, a podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love. I am Naji, your host, joined today by Karine Duquesne, Vice-President, General Manager of LEO Pharma France. Karine previously held the position of General Manager at Actelion Pharmaceuticals France, and Johnson & Johnson’s rare disease subsidiary prior to its merger with Janssen in 2020. She holds a Doctor of Pharmacy degree and has more than twenty years of experience in the pharmaceutical industry…

Do What You Enjoy – Marc de Garidel

SpreadLove In Organizations
SpreadLove In Organizations
Do What You Enjoy - Marc de Garidel
/

This episode is special and the first in a series of four. In partnership with ESCP Business School, I’ll be giving the mic to students, the leaders of tomorrow, to discuss with seasoned healthcare executives about their journeys and leadership beliefs. We welcomed in this first episode, Marc De Garidel Chief Executive Officer at Abivax. Marc shared his personal story and leadership beliefs with the students and several of his insightful learnings. In his closing advice, he encouraged aspiring leaders to pursue their passions, learn from mistakes, and not be overly concerned about others’ opinions.

“You can’t have impact if you don’t take risks at some point“

MEET OUR GUEST Marc De Garidel Chief Executive Officer at Abivax.

Marc De Garidel, is CEO of Abivax after being the CEO of CinCor Pharma, a biopharmaceutical company that develops therapies for patients with cardiovascular diseases and recently acquired by AstraZeneca.

Marc is a graduate of École Spéciale des Travaux Publics (a leading French civil engineering school), and holds a Master’s degree from Thunderbird School of Global Management and an Executive MBA from Harvard Business School. 

Marc began his career with Eli Lilly, then in 2000, he was appointed General Manager of Amgen’s French affiliate and progressively oversaw an increasing number of countries before heading the Southern region of Amgen International,  the group’s most important region in terms of sales.  In 2010, Marc left Amgen to become the CEO of Ipsen where he helped transform the company by focusing on research and development and expanding Ipsen’s international presence. Under his leadership, Ipsen’s market value increased significantly. Prior to joining CinCor, Marc served as CEO of Corvidia Therapeutics, a private Boston-based biotechnology company that was acquired by Novo Nordisk in August 2020.

In addition to that, Marc has had extensive non-profit responsibility as VP of EPFIA (Europe Pharma Association) for three years as well as chairing the French pharma association G5 for six years. Marc is also a recipient of the French Legion of Honor. 

Transcripts

EPISODE TRANSCRIPT: Marc De Garidel

Naji Gehchan: Hello, leaders of the world. Welcome to “Spread Love in Organizations”, a podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love. This episode is very special. In partnership with ESCP Business School, I’ll be giving the mic to students, our leaders of tomorrow, to discuss with incredible healthcare executives about their journeys and leadership beliefs. ESCP Students: Hello, we are Sarah Boutros and Bouchra Taha, Specialized Master’s students at ESCP Business School in Paris, and we are thrilled to be joined by an…

Do The Right Thing – Assaad Sayah

SpreadLove In Organizations
SpreadLove In Organizations
Do The Right Thing - Assaad Sayah
/

This episode is in partnership with MIT Sloan Healthcare and BioInnovations Conference, an event that brings the healthcare ecosystem together. We sat with Dr. Assaad Sayah CEO of Cambridge Health Alliance and discussed his personal story, his leadership beliefs, and the “Value-Based Care”, topic of his panel at the conference. Value = Quality / Cost, this is the way to think about value-based care; it has to be of great quality with the best patient experience at a contained cost. Health equity in this context is key. We need first of all to be in the underserved communities and be thoughtful, and purposeful about addressing their needs to narrow equities gaps. For Assaad, leadership is about providing the space for people to do the work, it is about trust, clarity, transparency, and accountability. The ultimate success of a “care delivery system” is for it to disappear because we worked on education, prevention, and screening for the community to remain healthy.

“Provide the space for people to do the work“

MEET OUR GUEST Assaad Sayah Chief Executive Officer Cambridge Health Alliance.

Dr. Assaad Sayah, President and CEO of Cambridge Health Alliance. Assaad was named CHA’s President and CEO in January 2020 after serving as the interim CEO since June 2019 and Chief Medical Officer since 2013.

Before that, Assaad served as the chief of emergency medicine and Senior Vice President of Primary Care. In the Emergency Department, he led tremendous advancements at all three CHA hospitals, resulting in enhanced efficiency, quality, volume, and patient satisfaction. He spearheaded primary care growth by more than 50 percent, expanding CHA’s access in underserved communities and integrating primary care and behavioral health services and systems to address social determinants of health. Assaad also plays a key role in CHA’s commitment to the communities it serves, including his tenure as the co-chair of the Cambridge City Manager’s Opioid Working Group established in 2018 to develop recommendations for strengthening the city’s response to the opioid epidemic.

Additionally, Assaad is Assistant Professor at Harvard Medical School. His research and publications focus on operational efficiency, improving the clinical environment, and patient experience of care.

Transcripts

EPISODE TRANSCRIPT: Assaad Sayah

Naji Gehchan: Hello, leaders of the world. Welcome to spread love in organizations, the podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love. I am Naji, your host for this special episode in partnership with MIT Sloan Healthcare and BioInnovations Conference, an event that brings the Healthcare Ecosystem Together. I am joined today Assaad Sayah, President and CEO of Cambridge Health Alliance. Assaad was named CHA’s President and CEO in January 2020 after serving as the interim CEO since June 2019 and chief medical officer…

The Eternal Optimist – Andrew Plump

SpreadLove In Organizations
SpreadLove In Organizations
The Eternal Optimist - Andrew Plump
/

This episode is in partnership with MIT Sloan Healthcare and BioInnovations Conference, an event that brings the healthcare ecosystem together. We sat with Andy Plump, President of R&D and Board Member at Takeda, and discussed his personal story, his leadership beliefs, and the “Challenges in Scaling Biotech Innovation” the topic of his panel at the conference. Hear his thoughts on the current and next decades of innovation, “will it be the decades of Life Science or Computer Science?” Most importantly, Andy leaves us with a message of hope. Every dark period in history anchored on the triad of war, pandemic, and social injustice has ended with greatness through science… We are on the edge of this, again, now.

“This decade will be remembered for Life Science or Computer Science… The potential is limitless.“

MEET OUR GUEST Andrew Plump President of Research & Development and Board Member at Takeda.

Dr. Andrew Plum is the President of Research & Development and a Board Member at Takeda. His career spans nearly 30 years in the pharmaceutical industry and academia.

Andy has been recognized for his contributions to the healthcare industry, education, and the arts. He serves on several non-profit boards including the Board of Trustees for the Boston Symphony Orchestra, the Sarnoff Cardiovascular Research Foundation, the Biomedical Science Careers Program, and as Chairman of the Board of Directors for the PhRMA Foundation.

Prior to Takeda, Andrew served as head of Research & Translational Medicine, deputy to the president of R&D at Sanofi, based in Paris, France. Prior to Sanofi, he served as worldwide cardiovascular research head at Merck.

Andy received his M.D. from the University of California, San Francisco (UCSF), his Ph.D. in cardiovascular genetics, and his B.S. from the Massachusetts Institute of Technology (MIT). He completed a residency in internal medicine and a fellowship in medical genetics at UCSF.

Transcripts

EPISODE TRANSCRIPT: Andrew Plump

Naji Gehchan: Hello, leaders of the world. Welcome to spread love in organizations, the podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love. I am Naji, your host for this special episode in partnership with MIT Sloan Healthcare and BioInnovations Conference, an event that brings the Healthcare Ecosystem Together. I am joined today Andrew Plump President of Research & Development and Board Member at Takeda. His career spans nearly 30 years in the pharmaceutical industry and academia. Andrew has been recognized for his contributions to…

Work to Make a Difference – Michael Ullmann

SpreadLove In Organizations
SpreadLove In Organizations
Work to Make a Difference - Michael Ullmann
/

Being in healthcare is a privilege and a humbling responsibility; we impact lives. This is what Michael Ullman has done throughout his years at Johnson & Johnson from where he retired recently as Executive VP, General Counsel & Executive Committee Member. Leadership for Mike is grounded in humility, kindness, and optimism, it is above all a responsibility to other people. Hear Mike’s experience leading JNJ to deliver on covid vaccine that saved humanity during the pandemic, and his thoughts on ESG, Health Equity, social responsibility, and how to build high-performing teams to ensure we deliver on our purpose. As leaders, our job is not to be superstars but rather shine through others, through our people’s greatness. Kindness is underused in the world, create a culture that demands it, treat people with respect, trust them, empower them, and help them succeed.

“Kindness is underused. Create a culture that demands it.”

MEET OUR GUEST Michael Ullmann, (Retired) Executive Vice President, General Counsel & Executive Committee Member, Johnson & Johnson

Michael Ullmann retired from Johnson & Johnson earlier this year after over 33 years with the Company.  For the last 11 years, he served as a member of the J&J Executive Committee and the Executive Vice President, General Counsel leading a global organization of over 2,000 employees in 60 countries encompassing Legal, Government Relations & Policy, ESG Strategy, Intellectual Property, Corporate Governance, Data Privacy, Compliance and Security. 

As General Counsel of the world’s largest Life Sciences company, he successfully guided JNJ through high-profile and high-risk situations, while helping to grow the business to annual sales of $94 billion, increase shareholder value and maintain its reputation as one of the most admired companies in the world. 

Mike joined Johnson & Johnson in 1989 as a mergers & acquisitions attorney and held various management positions, including General Counsel of the Worldwide Medical Devices Group, before becoming the company’s General Counsel in 2012. Michael is a member of the Board of Directors of Americares and serves on the Columbia Law School Board of Visitors. 

Transcripts

EPISODE TRANSCRIPT: Michael Ullmann

Naji Gehchan: Hello, leaders of the world. Welcome to spread love in organizations, the podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love. I am Naji, your host, joined today by Mike Ullmann. Mike retired from Johnson & Johnson earlier this year after over 33 years with the Company.  For the last 11 years, he served as a member of the J&J Executive Committee and the Executive Vice President, General Counsel leading a global organization of over 2,000 employees in 60 countries encompassing Legal, Government Relations & Policy, ESG Strategy, Intellectual Property, Corporate Governance, Data Privacy, Compliance and…